77 results
8-K
EX-99.1
NVRO
Nevro Corp
21 Feb 24
Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results
4:09pm
and not customer-facing personnel in the field to support the company’s long-term growth and profitability.
For the full-year and first-quarter of 2024
8-K
EX-99.1
NVRO
Nevro Corp
9 Jan 24
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results
8:41am
employees and not customer-facing personnel in the field.
Financial Highlights
Fourth-quarter 2023 worldwide revenue of approximately $116.0
8-K
EX-10.1
NVRO
Nevro Corp
1 Dec 23
Nevro Announces Acquisition of Vyrsa™ Technologies
6:07am
authorities under applicable “know your customer” and anti-money laundering rules and regulations, including the Patriot Act and the Beneficial
8-K
EX-2.1
p6jpolrzpy8rggwjb2ke
1 Dec 23
Nevro Announces Acquisition of Vyrsa™ Technologies
6:07am
8-K
EX-99.1
hzshb tncxq0ueps6mzt
19 Apr 23
Results of Operations and Financial Condition
5:07pm
8-K
43oqucb1kp32l 687
19 Apr 23
Results of Operations and Financial Condition
5:07pm
8-K
EX-99.1
mgnxck0qr6ze71zk1
2 Nov 22
Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy
4:14pm
8-K
EX-99.1
1ju3 a6qw1a8
3 Aug 22
Nevro Reports Second Quarter 2022 Financial Results, Provides Third Quarter 2022 Guidance and Updates Full-Year 2022 Guidance
4:18pm
8-K
EX-99.1
sxskphhtlrx26f zw
8 Nov 21
Nevro Reports Third Quarter 2021 Financial Results and Provides Fourth Quarter Guidance
4:18pm